Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, Open Label, Multicentre Phase-III Clinical Trial to Compare the Efficacy and Safety of the Treatment With the Autologous Chondrocyte Transplantation Product co.Don Chondrosphere (ACT3D-CS) With Microfracture in Subjects With Cartilage Defects of the Knee With a Defect Size Between 1 an 4 cm2

NCT01222559 is registered in ClinicalTrials.gov with co.don AG as lead sponsor.

NCT NCT01222559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01222559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, Open Label, Multicentre Phase-III Clinical Trial to Compare the Efficacy and Safety of the Treatment With the Autologous Chondrocyte Transplantation Product co.Don Chondrosphere (ACT3D-CS) With Microfracture in Subjects With Cartilage Defects of the Knee With a Defect Size Between 1 an 4 cm2
Lead sponsor
co.don AG
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
February 29, 2020
Enrollment
102 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage lesion of the femoral condyle